Health Technology Assessment Subcategories
Decision & Deliberative Processes
-
Recommendations on the Use of Structured Expert Elicitation Protocols for Healthcare Decision Making
-
Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist
-
Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Designing and Implementing Deliberative Processes for Health Technology Assessment: Joint HTAi/ISPOR Task Force Report
-
Being Precise About Precision Medicine: Report of the ISPOR Personalized Precision Medicine Special Interest Group
-
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
-
Challenges in Research and Health Technology Assessment of Rare Disease Technologies:
-
Multiple Criteria Decision Analysis for Health Care Decision Making - An Introduction: Report 1
-
Multiple Criteria Decision Analysis for Health Care Decision Making - Emerging Good Practices: Report 2
-
Transferability of Economic Evaluations Across Jurisdictions - Good research practices task force report
-
Use of Pharmacoeconomics Information
Systems & Structure
Value Frameworks & Dossier Format
-
A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars
-
A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report 1
-
An Overview of Value, Perspective, and Decision Context—A Health Economics Approach: An ISPOR Special Task Force Report 2
-
Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report 3
-
Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report 4
-
Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report 5
-
Review of Recent US Value Frameworks—A Health Economics Approach: An ISPOR Special Task Force Report 6
-
A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report 7
All Health Technology Assessment Reports
Please Note: Reports are in reverse chronological order.
-
Recommendations on the Use of Structured Expert Elicitation Protocols for Healthcare Decision Making
-
Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist
-
Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment
-
Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems
-
Designing and Implementing Deliberative Processes for Health Technology Assessment: Joint HTAi/ISPOR Task Force Report
-
Being Precise About Precision Medicine: Report of the ISPOR Personalized Precision Medicine Special Interest Group
-
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
-
Challenges in Research and Health Technology Assessment of Rare Disease Technologies:
-
A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report 7
-
A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report 1
-
Review of Recent US Value Frameworks—A Health Economics Approach: An ISPOR Special Task Force Report 6
-
Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report 5
-
Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report 4
-
An Overview of Value, Perspective, and Decision Context—A Health Economics Approach: An ISPOR Special Task Force Report 2
-
Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report 3
-
Multiple Criteria Decision Analysis for Health Care Decision Making - An Introduction: Report 1
-
Multiple Criteria Decision Analysis for Health Care Decision Making - Emerging Good Practices: Report 2
-
A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars
-
Transferability of Economic Evaluations Across Jurisdictions - Good research practices task force report
-
Use of Pharmacoeconomics Information